These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4320865)

  • 1. Quantitation of the antigenicity and immunogenicity of purified foot-and-mouth disease virus vaccine for swine and steers.
    Morgan DO; McKercher PD; Bachrach HL
    Appl Microbiol; 1970 Nov; 20(5):770-4. PubMed ID: 4320865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experiments on vaccination of pigs with ethyl-ethyleneimine (EEI) diethylaminoethyl dextran (DEAE-D) foot-and-mouth disease vaccines. Influence of route of inoculation and dose of antigen on the duration of immunity.
    Wittmann G; Bauer K; Mussgay M
    Arch Gesamte Virusforsch; 1972; 36(3):251-64. PubMed ID: 4336493
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine in cattle using a direct contact transmission model.
    Neilan JG; Schutta C; Barrera J; Pisano M; Zsak L; Hartwig E; Rasmussen MV; Kamicker BJ; Ettyreddy D; Brough DE; Butman BT; Brake DA
    BMC Vet Res; 2018 Aug; 14(1):254. PubMed ID: 30157853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of guinea-pigs against foot-and-mouth disease by simultaneous inoculation of sendai virus and inactivated foot-and-mouth disease vaccine.
    Herniman KA; Sellers RF
    Arch Gesamte Virusforsch; 1972; 37(1):97-103. PubMed ID: 4336969
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasmids encoding foot-and-mouth disease virus VP1 epitopes elicited immune responses in mice and swine and protected swine against viral infection.
    Wong HT; Cheng SC; Chan EW; Sheng ZT; Yan WY; Zheng ZX; Xie Y
    Virology; 2000 Dec; 278(1):27-35. PubMed ID: 11112477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A DNA vaccine against foot-and-mouth disease elicits an immune response in swine which is enhanced by co-administration with interleukin-2.
    Wong HT; Cheng SC; Sin FW; Chan EW; Sheng ZT; Xie Y
    Vaccine; 2002 Jun; 20(21-22):2641-7. PubMed ID: 12034088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A complex-trapping-blocking (CTB) ELISA, using monoclonal antibodies and detecting specifically antibodies directed against foot-and-mouth disease types A, O and C. II. Application.
    van Maanen C
    Vet Microbiol; 1990 Aug; 24(2):179-91. PubMed ID: 2173249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of ENABL® adjuvant to increase the potency of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine.
    Barrera J; Schutta C; Pisano M; Grubman MJ; Brake DA; Miller T; Kamicker BJ; Olutunmbi F; Ettyreddy D; Brough DE; Butman BT; Neilan JG
    Vaccine; 2018 Feb; 36(8):1078-1084. PubMed ID: 29358056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic response of lambs to emulsified foot-and-mouth disease vaccine.
    Cunliffe HR; Graves JH
    Arch Gesamte Virusforsch; 1970; 32(2):261-8. PubMed ID: 4322844
    [No Abstract]   [Full Text] [Related]  

  • 10. The biological relevance of virus neutralisation sites for virulence and vaccine protection in the guinea pig model of foot-and-mouth disease.
    Dunn CS; Samuel AR; Pullen LA; Anderson J
    Virology; 1998 Jul; 247(1):51-61. PubMed ID: 9683571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maturation of functional antibody affinity in animals immunised with synthetic foot-and-mouth disease virus.
    Mulcahy G; Reid E; Dimarchi RD; Gale C; Doel TR
    Res Vet Sci; 1992 Mar; 52(2):133-40. PubMed ID: 1316628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategy for producing new foot-and-mouth disease vaccines that display complex epitopes.
    McKenna TS; Rieder E; Lubroth J; Burrage T; Baxt B; Mason PW
    J Biotechnol; 1996 Jan; 44(1-3):83-9. PubMed ID: 8717390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of namogram to milligram quantities of inactivated foot-and-mouth disease virus. I. Relative virus-neutralizing potency of guinea pig sera.
    Morgan DO; Bachrach HL; McKercher PD
    Appl Microbiol; 1969 Mar; 17(3):441-5. PubMed ID: 4305396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccines prepared from chimeras of foot-and-mouth disease virus (FMDV) induce neutralizing antibodies and protective immunity to multiple serotypes of FMDV.
    Rieder E; Baxt B; Lubroth J; Mason PW
    J Virol; 1994 Nov; 68(11):7092-8. PubMed ID: 7523697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved immune responses and safety of foot-and-mouth disease vaccine containing immunostimulating components in pigs.
    Choi JH; You SH; Ko MK; Jo HE; Shin SH; Jo H; Lee MJ; Kim SM; Kim B; Lee JS; Park JH
    J Vet Sci; 2020 Sep; 21(5):e74. PubMed ID: 33016020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined administration of synthetic RNA and a conventional vaccine improves immune responses and protection against foot-and-mouth disease virus in swine.
    Borrego B; Blanco E; Rodríguez Pulido M; Mateos F; Lorenzo G; Cardillo S; Smitsaart E; Sobrino F; Sáiz M
    Antiviral Res; 2017 Jun; 142():30-36. PubMed ID: 28315707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of protective immunity in swine by immunization with live attenuated recombinant pseudorabies virus expressing the capsid precursor encoding regions of foot-and-mouth disease virus.
    Li X; Liu R; Tang H; Jin M; Chen H; Qian P
    Vaccine; 2008 May; 26(22):2714-22. PubMed ID: 18436351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of the immune response to foot and mouth disease virus vaccine in calves by using Avridine as adjuvant.
    Sadir AM; Zamorano PI; Romera A; Wigdorovitz A; Smitsaart E; Marangunich L; Schiappacassi C; Borca MV
    Vet Immunol Immunopathol; 1999 Jul; 69(1):11-22. PubMed ID: 10490231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mincle and STING-Stimulating Adjuvants Elicit Robust Cellular Immunity and Drive Long-Lasting Memory Responses in a Foot-and-Mouth Disease Vaccine.
    Lee MJ; Jo H; Shin SH; Kim SM; Kim B; Shim HS; Park JH
    Front Immunol; 2019; 10():2509. PubMed ID: 31736952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of a high potency O1 Manisa monovalent vaccine against heterologous challenge with foot-and-mouth disease virus of O/SEA/Mya-98 lineage in sheep.
    Singanallur NB; Pacheco JM; Arzt J; Stenfeldt C; Fosgate GT; Rodriguez L; Vosloo W
    Antiviral Res; 2017 Sep; 145():114-122. PubMed ID: 28780422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.